Serina Therapeutics News

Serina Therapeutics Files Registration Statement for Potential Offering of Common Stock, Warrants

Serina Therapeutics (SER) on Friday filed a registration statement for the potential offering of up to about 3 million common shares issuable upon warrant exercises, and up to about 1.5 million warran

MT NewswiresMay 6 18:10

Serina Therapeutics Files to Sell 1.5M Shares of Common Stock

Seeking AlphaMay 4 05:45

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

- Dr. Gill brings extensive leadership experience in transformative biotechnology platforms and drug development - HUNTSVILLE, AL, April 17, 2024 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (NYSE:SER), a

GlobeNewswireApr 18 04:05

Serina Therapeutics: Strategic Restructuring and Merger Success

TipRanksApr 2 05:42

News On AgeX Therapeutics Inc. (AGE) Now Under SER

News On AgeX Therapeutics Inc. (AGE) Now Under SER

Dow JonesMar 28 05:08

Serina Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 61.6%

Serina Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 61.6%

BenzingaMar 27 22:04

Serina Therapeutics Announces Completion of Merger With AgeX Therapeutics

Shares of Serina to commence trading on NYSE American under the ticker symbol "SER" on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024;

GlobeNewswireMar 27 05:04

AgeX Therapeutics GAAP EPS of -$13.73

Seeking AlphaMar 25 12:59

AgeX Therapeutics Secures Funding, Details in SEC Report

TipRanksFeb 15 05:38

AgeX Therapeutics Postpones Merger Completion With Serina

TipRanksFeb 7 17:45

AgeX Therapeutics Expands Ties With JuvVentures Equity Deal

TipRanksFeb 7 17:44

AgeX Therapeutics Secures $500K Convertible Note Deal

TipRanksFeb 7 17:44

What's Going On With Penny Stock AgeX Therapeutics?

Serina Therapeutics Inc, a privately held, clinical-stage biotechnology company, entered into a License Agreement under which Pfizer Inc (NYSE:PFE) will license, on a non-exclusive basis, Serina's POZ polymer technology.

BenzingaNov 18, 2023 02:10

AgeX Therapeutics Continues To Slide

RTTNewsNov 17, 2023 23:18

Serina Therapeutics Announces POZ Polymer Technology License Agreement With Pfizer

Provides access to Serina POZ polymer technology for potential use in lipid nanoparticle (LNP) formulations HUNTSVILLE, AL, Nov. 17, 2023 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (Serina), a privately held,

GlobeNewswireNov 17, 2023 21:00

AgeX Therapeutics Q3 EPS $(0.14) Down From $(0.06) YoY, Sales $67.00K Up From $9.00K YoY

AgeX Therapeutics (AMEX:AGE) reported quarterly losses of $(0.14) per share. This is a 133.33 percent decrease over losses of $(0.06) per share from the same period last year. The company reported $6

BenzingaNov 15, 2023 05:56

AgeX Therapeutics Restructures Debt, Faces Financial Uncertainty

InvestingNov 15, 2023 05:50

Earnings Flash (AGE) AGEX THERAPEUTICS Posts Q3 Revenue $67,000

04:19 PM EST, 11/14/2023 (MT Newswires) -- Earnings Flash (AGE) AGEX THERAPEUTICS Posts Q3 Revenue $67,000

MT NewswiresNov 15, 2023 05:19

Press Release: AgeX Therapeutics Reports Third Quarter 2023 Financial Results

AgeX Therapeutics Reports Third Quarter 2023 Financial Results ALAMEDA, Calif.--(BUSINESS WIRE)--November 14, 2023-- AgeX Therapeutics, Inc. ("AgeX"; NYSE American: AGE), a biotechnology company dev

Dow JonesNov 15, 2023 05:06

AgeX Therapeutics 3Q Rev $67,000 >AGE

AgeX Therapeutics 3Q Rev $67,000 >AGE

Dow JonesNov 15, 2023 05:05